MentionFox
Home › Executive changes › Avanos Medical, Inc.
Leadership changes · SEC Form 8-K, Item 5.02

Avanos Medical, Inc. executive changes

Every leadership change Avanos Medical, Inc. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Appointments named1
Latest filing2026-07-30

Avanos Medical, Inc. filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-30. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-07-30 · 8-K

Appointed: John S. Fischer, General Counsel

The following table sets forth the name and title of each officer who was appointed: Name Title David C. Pacitti President and Chief Executive Officer Scott M. Galovan Vice President, Chief Financial Officer and Treasurer John S. Fischer General Counsel and Secretary Biographies of each of David C. Pacitti and Scott M. Galovan are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 under the caption "Directors, Executive Officers, and Corporate Governance." John S. Fischer, age 68, was appointed as the Company's General Counsel and Secretary on July 27, 2
Hiring for a seat like this?

Find people with the same kind of experience as the General Counsel at Avanos Medical, Inc., with the record behind each one.

Find candidates like General Counsel at Avanos Medical, Inc.
Selling to Avanos Medical, Inc.?

New leaders review vendors and budgets in their first months. Get an alert the next time Avanos Medical, Inc. is in the news or changes leadership.

Get an alert when Avanos Medical, Inc. changes leadership

Tools for this story

Each opens in a new tab, filled in for Avanos Medical, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/avanos-medical
Last updated 2026-09-27
Primary record: SEC filing
Avanos Medical, Inc. (AVNS) executive changes: John S. Fischer appointed, General Counsel. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/avanos-medical